SCHEMBL5146458

SCHEMBL5146458

FC(F)Oc1ccc([C]2CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 2/20 0.52
ATM Q13315 4/20 0.41
ALDH1A1 P00352 4/20 0.41
HTT P42858 3/20 0.41
ALOX15 P16050 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
HSP90AA1 P07900 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
CCR6 P51684 1/20 0.41
KMT2A Q03164 1/20 0.41
GFER P55789 1/20 0.41
ADAM17 P78536 1/20 0.41
SLC6A4 P31645 1/20 0.40
SCN5A Q14524 1/20 0.38
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.36
RAB9A P51151 2/20 0.36
MAT2A P31153 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5144861 0.91 DRD1 (0.48) DRD1ATMALDH1A1HTTALOX15
SCHEMBL5147781 0.91 DRD1 (0.48) DRD1ATMALDH1A1HTTALOX15
SCHEMBL5144843 0.90 DRD1 (0.47) DRD1ATMALDH1A1HTTALOX15
SCHEMBL13264261 0.83 DRD1 (0.68) DRD1ATMALDH1A1HTTALOX15
SCHEMBL11065049 0.80 DRD1 (0.56) DRD1ATMALDH1A1HTTALOX15
SCHEMBL9060628 0.73 DRD1 (0.57) DRD1ATMALDH1A1HTTALOX15
SCHEMBL9061683 0.73 DRD1 (0.57) DRD1ALDH1A1HTTMAPTRAB9A
SCHEMBL13906279 0.73 DRD1 (0.57) DRD1ATMALDH1A1HTTALOX15
SCHEMBL3536741 0.73 DRD1 (0.57) DRD1ATMALDH1A1HTTALOX15
SCHEMBL533356 0.71 DRD1 (0.55) DRD1ATMALDH1A1HTTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299072-A1 KV1.5 POTASSIUM CHANNEL INHIBITORS WYETH (US) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299072-A1 KV1.5 POTASSIUM CHANNEL INHIBITORS KCNA5, KCNH1, KCNK5 DRD1 1811/4885ATM 4248/4885ALDH1A1 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.